Literature DB >> 15735434

Determinants of life satisfaction in inflammatory bowel disease.

Karl-Heinz Janke1, Bodo Klump, Michael Gregor, Christoph Meisner, Winfried Haeuser.   

Abstract

UNLABELLED: In patients with Crohn's disease (CD) and ulcerative colitis (UC), medical, sociodemographic, and psychologic "risk and protective" factors for general and health-related life satisfaction (GLS and HRLS, respectively)--defined as preference-based judgments of general and health-related quality of life--have not been studied to date.
METHODS: A total of 429 of 868 (49%) outpatients (CD, n = 317; UC, n = 112) attending 3 tertiary care centers and members of the German Crohn's Disease/Ulcerative Colitis Foundation completed the sociodemographic and medical questionnaires of the German "Competence Network Inflammatory Bowel Diseases," the Hospital Anxiety and Depression Scale, and the "Questions on Life Satisfaction(Modules)". Disease activity was assessed by the German Inflammatory Bowel Disease Activity Index. "Questions on Life Satisfaction(Modules)" data were compared with a representative sample of the German general population.
RESULTS: GLS and HRLS were reduced compared with the general German population (P < 0.005). Logistic regression showed that mental disorder was a risk factor of reduced GLS in CD [odds-ratio (OR), 2.7; P < 0.01] and UC (OR, 6.3; P < 0.02). Membership in a self-help organization offered no protection against reduced GLS in CD (OR, 0.5; P < 0.02). In CD, psychiatric (OR, 10.4; P < 0.01) and medical comorbidity (OR, 2.0; P < 0.02) and disease activity (OR, 4.0; P < 0.01) were risk factors of reduced HRLS, whereas in UC, only disease activity (OR, 6.6; P < 0.01) predicted reduced HRLS.
CONCLUSIONS: To improve GLS and HRLS in inflammatory bowel disease, both the treatment of bowel disease and medical and psychiatric comorbidity are necessary. Strengthening of social support is an additional way to promote GLS.

Entities:  

Mesh:

Year:  2005        PMID: 15735434     DOI: 10.1097/01.mib.0000160809.38611.f7

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  28 in total

1.  Anxiety and depression in adult patients with celiac disease on a gluten-free diet.

Authors:  Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Michael Gregor; Andreas Hinz
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients.

Authors:  Thomas N Hyphantis; Barbara Tomenson; Marina Bai; Epameinondas Tsianos; Venetsanos Mavreas; Francis Creed
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

3.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  An 18-month study of the effects of IBD symptomatology and emotion regulation on depressed mood.

Authors:  Inês A Trindade; Cláudia Ferreira; Mariana Moura-Ramos; José Pinto-Gouveia
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

Review 5.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 6.  Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease.

Authors:  Sharon Jedel; Megan M Hood; Ali Keshavarzian
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

7.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

8.  Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.

Authors:  Thiago H Freitas; Elias Andreoulakis; Gilberto S Alves; Hesley L L Miranda; Lúcia L B C Braga; Thomas Hyphantis; André F Carvalho
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 9.  Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review.

Authors:  Winfried Häuser; Gabriele Moser; Petra Klose; Antonina Mikocka-Walus
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

10.  Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.

Authors:  Daniel B Zandman; Mark A Peppercorn
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.